Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2010
08/05/2010US20100196467 Therapeutic combination of amlodipine and benazepril/benazeprilat
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196441 Uses of immunologically modified scaffold for tissue prevascularization cell transplantation
08/05/2010US20100196433 Prevascularized devices and related methods
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196387 Disulfide, Sulfide, Sulfoxide, and Sulfone Derivatives of Cyclic Sugars and Uses Thereof
08/05/2010US20100196367 Methods For Screening Candidate Agents For Modulating Prorenin And Renin, Assays for Detecting Prorenin And Antibodies
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196348 COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN
08/05/2010US20100196345 Production of high mannose proteins in plant culture
08/05/2010US20100196338 Compositions and methods for treating cardiovascular disease
08/05/2010US20100196322 Polymer for tissue engineering applications and drug delivery
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196314 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196313 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196284 Ultrasound Imaging with Targeted Microbubbles
08/05/2010US20100196264 Use of somatostatin analogs in myocardial perfusion imaging
08/05/2010DE102009006602A1 Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2751125A1 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010CA2751033A1 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/05/2010CA2750835A1 Carboxamide compounds and methods for using the same
08/05/2010CA2750710A1 Fused ring compound and use thereof
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213669A1 Crystalline imidazol-5-carboxylic acid derivate
08/04/2010EP2213666A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2213286A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes and cardiovascular diseases
08/04/2010EP2212416A1 Uses of a glycoprotein vi (gpvi) inhibitor
08/04/2010EP2212317A1 4,4-disubstituted piperidines
08/04/2010EP2212315A1 Trisubstituted piperidines
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212303A1 Novel benzamide derivatives useful as potassium channel modulators
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/04/2010EP2211898A2 Novel patient subgroups for thrombolysis
08/04/2010EP2211894A2 Inhibition of urokinase-type plasminogen activator (upa) activity
08/04/2010EP2211872A1 Hyperbranched polyglycerol for improving heart function
08/04/2010EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases
08/04/2010EP1667976B1 Isoquinolinone potassium channel inhibitors
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010EP1636365B1 Cholesterol biosynthesis pathway modulators and uses thereof
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/04/2010CN1915222B Composition of liposome, and preparation method
08/04/2010CN1896094B Use of angiotensin II receptors I immunogenic peptide section
08/04/2010CN101796039A Phenylacetic acid compound
08/04/2010CN101796033A Substituted piperazines as CB1 antagonists
08/04/2010CN101796032A Substituted piperazines as CB1 antagonists
08/04/2010CN101795690A Method for reducing intracranial pressure
08/04/2010CN101792788A Preparation method of 5'-acylated cytidine and application in preparing medicaments for treating heart and liver diseases
08/04/2010CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
08/04/2010CN101791391A Traditional Chinese medicine composition for treatment of cardiovascular infarction syndrome and preparation method thereof
08/04/2010CN101791390A Traditional Chinese medicine compound composition for treating sequelae of cerebral infarction and cerebral hemorrhage and processing method thereof
08/04/2010CN101791378A Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration
08/04/2010CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera
08/04/2010CN101791362A Traditional Chinese medicine preparation for treatment of apoplexy
08/04/2010CN101791342A Uncaria extract and application thereof in preparing medicines for reducing blood fat and resisting cardiac hypertrophy
08/04/2010CN101791340A Method for purifying active ingredients of compound Naodesheng
08/04/2010CN101791335A Total alkaloid mixture sourcing from Chinese medicina plant lotus plumule and extraction and preparation method thereof
08/04/2010CN101791334A Circulation promoting agaricus blazei polysaccharide health-care capsule
08/04/2010CN101791332A Compound gingko health product solid preparation
08/04/2010CN101791331A Method for rapid determination of tannin content in Slvia Miltiorrhiza Bunge extracting solution
08/04/2010CN101791324A Preparation process of Ilex latifolia Thunb extractive
08/04/2010CN101791323A Ginkgo biloba extract dripping pill and preparation method thereof
08/04/2010CN101791320A Application of nano carbon particles in preparing external medicament for curing haemorrhoids and external medicament
08/04/2010CN101791318A Novel application of bacterial lipopolysaccharides
08/04/2010CN101791311A Pharmaceutical composition with short pressure-reducing function
08/04/2010CN101791310A Vinpocetine medicine composition and preparation method thereof
08/04/2010CN101791309A Oral solid preparation containing clopidogrel hydrogen sulfate
08/04/2010CN101791304A Application of Xyloketal B in preparing medicines for treating mitochondrial injury diseases
08/04/2010CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof
08/04/2010CN101791290A Tetra-acetylated puerarin self-micro emulsifying medicament delivery system and preparation method thereof
08/04/2010CN101103033B Triazolophthalazines as PDE2-inhibitors
08/04/2010CN101028503B Oral Chinese-medicine composition for treating Raynaud's disease
08/03/2010US7767830 Synthesis of antiarrhythmic vernakalant hydrochloride in stereoisomerically substantially pure form starting with microbial oxidation of a monohalobenzene to the cyclohexanediol and amination with a 3-pyrrolidinol; arrhythmia; O-benzyl protected intermediate
08/03/2010US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767677 Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767665 1,3-benzothiazinone derivatives and use thereof
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767236 safflower seed extract prepared by washing a defatted safflower seed with water to obtain a washed product, separating the washed product from a resulting washing liquid, and extracting the washed product with an organic solvent; for reducing risk of developing atherosclerosis
08/03/2010US7767227 Galenical form for oral administration with prolonged release of molsidomine
08/03/2010US7767208 Noninvasive vascular therapy
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010US7767201 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
08/03/2010CA2661728C Generation of therapeutic microfoam
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2247247C Troponin subunits and fragments useful as angiogenesis inhibitors
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 1595